Cochrane · systematic review · CD012680

Adjuvant therapy with antidepressants for the management of inflammatory bowel disease

Mikocka‐Walus, A, Prady, SL, Pollok, J, et al. · Cochrane Database of Systematic Reviews · 2019 · Cochrane Library

GutAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
9
current version
GRADE rated
8
No studies
1
Included studies
NR
No studies 1 · 11.1%Ungraded 0 · 0%Very low 1 · 11.1%Low 7 · 77.8%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Antidepressants compared to placebo for inflammatory bowel disease

Population: participants with active and inactive inflammatory bowel disease
9 questions
OutcomeEffectEvidenceStatus / GRADE
Anxiety at 12 weeks
Antidepressants vs placebo
no estimate extracted1 study · 44 participantsLow
Downgraded: imprecision
Anxiety at 12 months
Antidepressants vs placebo
no estimate extracted1 study · 26 participantsLow
Downgraded: risk of bias, imprecision
Depression at 12 weeks
Antidepressants vs placebo
no estimate extracted1 study · 44 participantsLow
Downgraded: imprecision
Depression at 12 months
Antidepressants vs placebo
no estimate extracted1 study · 26 participantsLow
Downgraded: risk of bias, imprecision
Adverse events at 12 months
Antidepressants vs placebo
RR 2.29 [0.78, 6.73]1 study · 26 participantsLow
Downgraded: risk of bias, imprecision
Quality of life
Antidepressants vs placebo
no estimate extracted2 studies · 70 participantsLow
Downgraded: imprecision
Pain
Antidepressants vs placebo
no estimate extractedNRNo studies
Maintenance of remission at 12 months
Antidepressants vs placebo
RR 0.96 [0.55, 1.69]1 study · 26 participantsLow
Downgraded: risk of bias, imprecision
Endoscopic relapse at 12 months
Antidepressants vs placebo
RR 0.14 [0.01, 2.65]1 study · 60 participantsVery low
Downgraded: risk of bias, imprecision